Literature DB >> 28339434

Platelet Rich Plasma in Musculoskeletal Pathology: A Necessary Rescue or a Lost Cause?

Annu Navani1, Gang Li2, Joshua Chrystal3.   

Abstract

BACKGROUND: Platelet rich plasma (PRP) has been used for decades to facilitate surgical tissue repair; therefore, the current trend of percutaneously injecting PRP to theoretically enhance tissue regeneration and repair is a logical progression. Applications include treatment of osteoarthritis, tendinopathy, chondropathy, acute and chronic soft tissue injuries, muscle or ligament tear, as well as enhancement of healing after bone or tissue reconstruction. However, there is limited evidence to support the use of PRP in the abovementioned conditions. Variations in the preparation of PRP and its application in various conditions influence its effect on various orthopedic conditions.
OBJECTIVE: To provide a basic overview of the current use of PRP in treating musculoskeletal conditions.
METHODS: Studies relevant to PRP were extracted from the PubMed and Medline database within the dates ranging from 1990 through 2015. These studies included in vitro as well as in-vivo animal experiments and careful analysis of the study population, type of intervention, and outcomes was made.
RESULTS: PRP has been noted to be a beneficial solution for tissue healing based on limited current literature. However a variety of factors such as method of preparation, composition, medical condition of the patient, anatomic location of the lesion, and tissue type can alter outcome.
CONCLUSION: The effectiveness and potential adverse effects of this treatment require high quality studies prior to widespread clinical application.Key words: Growth factors, platelet rich plasma, regeneration, regenerative healing, tissue repair, stem cells, mesenchymal stem cells, tissue engineering.

Entities:  

Mesh:

Year:  2017        PMID: 28339434

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  6 in total

Review 1.  In vitro evidence supporting applications of platelet derivatives in regenerative medicine.

Authors:  Ilaria Giusti; Sandra D'Ascenzo; Guido Macchiarelli; Vincenza Dolo
Journal:  Blood Transfus       Date:  2019-10-08       Impact factor: 3.443

2.  Efficacy of Ultrasound-Guided Glenohumeral Joint Injections of Leukocyte-Poor Platelet-Rich Plasma Versus Hyaluronic Acid in the Treatment of Glenohumeral Osteoarthritis: A Randomized, Double-Blind Controlled Trial.

Authors:  Jonathan S Kirschner; Jennifer Cheng; Andrew Creighton; Kristen Santiago; Nicole Hurwitz; Mark Dundas; Nicholas Beatty; Dallas Kingsbury; Gabrielle Konin; Zafir Abutalib; Richard Chang
Journal:  Clin J Sport Med       Date:  2022-03-17       Impact factor: 3.454

3.  Nanotopographic cues and stiffness control of tendon-derived stem cells from diverse conditions.

Authors:  Sun Jeong Kim; Philip D Tatman; Da-Hyun Song; Albert O Gee; Deok-Ho Kim; Sang Jun Kim
Journal:  Int J Nanomedicine       Date:  2018-11-08

4.  Turn down - turn up: a simple and low-cost protocol for preparing platelet-rich plasma.

Authors:  Edilson Silva Machado; Renata Leite; Cintia Cichowski Dos Santos; Georgia Lazzari Artuso; Fernando Gluszczak; Leonardo Giovani de Jesus; José Manuel Peixoto Caldas; Markus Bredemeier
Journal:  Clinics (Sao Paulo)       Date:  2019-08-19       Impact factor: 2.365

5.  Efficacy of Autologous Conditioned Serum (ACS), Platelet-Rich Plasma (PRP), Hyaluronic Acid (HA) and Steroid for Early Osteoarthritis Knee: A Comparative Analysis.

Authors:  Ankit Khurana; Ashish Goyal; P Kirubakaran; Gaurav Akhand; Rishi Gupta; Navneet Goel
Journal:  Indian J Orthop       Date:  2020-10-08       Impact factor: 1.251

6.  Optimal activation methods for maximizing the concentrations of platelet-derived growth factor-BB and transforming growth factor-β1 in equine platelet-rich plasma.

Authors:  Kentaro Fukuda; Taisuke Kuroda; Norihisa Tamura; Hiroshi Mita; Yoshinori Kasashima
Journal:  J Vet Med Sci       Date:  2020-08-19       Impact factor: 1.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.